- Home
- DXCM vs LII Comparison
DXCM vs LII Comparison
Compare DXCM & LII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXCM
- LII
- Stock Information
- Founded
- DXCM 1999
- LII 1895
- Country
- DXCM United States
- LII United States
- Employees
- DXCM N/A
- LII N/A
- Industry
- DXCM Medical/Dental Instruments
- LII Industrial Machinery/Components
- Sector
- DXCM Health Care
- LII Industrials
- Exchange
- DXCM Nasdaq
- LII Nasdaq
- Market Cap
- DXCM 34.1B
- LII 20.6B
- IPO Year
- DXCM 2005
- LII 1999
- Fundamental
- Price
- DXCM $82.93
- LII $604.22
- Analyst Decision
- DXCM Strong Buy
- LII Hold
- Analyst Count
- DXCM 20
- LII 11
- Target Price
- DXCM $98.50
- LII $594.70
- AVG Volume (30 Days)
- DXCM 3.7M
- LII 364.1K
- Earning Date
- DXCM 07-30-2025
- LII 07-23-2025
- Dividend Yield
- DXCM N/A
- LII 0.86%
- EPS Growth
- DXCM N/A
- LII 30.10
- EPS
- DXCM 1.33
- LII 22.45
- Revenue
- DXCM $4,148,000,000.00
- LII $5,366,800,000.00
- Revenue This Year
- DXCM $16.74
- LII $3.33
- Revenue Next Year
- DXCM $15.29
- LII $5.56
- P/E Ratio
- DXCM $62.25
- LII $26.92
- Revenue Growth
- DXCM 9.11
- LII 7.78
- 52 Week Low
- DXCM $57.52
- LII $500.10
- 52 Week High
- DXCM $117.19
- LII $682.50
- Technical
- Relative Strength Index (RSI)
- DXCM 48.21
- LII 69.36
- Support Level
- DXCM $82.75
- LII $555.27
- Resistance Level
- DXCM $87.49
- LII $571.80
- Average True Range (ATR)
- DXCM 2.64
- LII 12.34
- MACD
- DXCM -0.16
- LII 6.31
- Stochastic Oscillator
- DXCM 48.72
- LII 96.83
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
About LII Lennox International Inc.
Lennox International manufactures and distributes heating, ventilating, air conditioning, and refrigeration products to replacement (75% of sales) and new construction (25% of sales) markets. In fiscal 2024, residential HVAC was 67% of sales and commercial HVAC and Heatcraft refrigeration was 33% of sales. The company goes to market with multiple brands, but Lennox is the company's flagship HVAC brand. The Texas-based company is focused on North America after the sale of its European HVAC and refrigeration businesses in late 2023.